Hsiu Chi Chang

Hsiu Chi Chang currently works at Yuanhua Biotechnology Co., Ltd., as Chairman, Yuen Hung Investment Co. Ltd., as Chairman, Top Horizon Holdings Ltd., as Director, Worldco International Co. Ltd., as Director, Purzer Pharmaceutical Co. Ltd., as Director & General Manager, HealthBaby Biotech (Hong Kong) Co., Ltd., as Director, Xudong Haipu International Co. Ltd., as Director, Healthbanks Biotech Co., Ltd., as Director, Reber Genetics Co., Ltd., as Director from 2011, Ku Bao Biological Technology Co., Ltd., as Director, Da Long Biotechnology Co., Ltd., as Director, Technical Associate Management Consultant Co., Ltd., as Director, Asiacord Biotech (BVI) Co.,Ltd, as Director, Stemgen Biotech Holding Ltd., as Director, Kang Ziya Co., Ltd., as Director, Aaxter Co., Ltd., as Director, Sheng Pao Biotech Co. Ltd., as Director, Worldco Biotech Pharm Pharmaceutical Technology Beijing Ltd., as Director, Kamzea Corp.
Ltd., as Director, and China Steel Structure Co., Ltd., as President from 2022.
Mr. Chang also formerly worked at Annji Pharmaceutical Co., Ltd., as Chairman, TSH Biopharm Corp., Ltd., as Director-Supervisory Board, Shengyang Biopharm (Hong Kong) Ltd., as Director-Supervisory Board, TTY Biopharm Co. Ltd., as Director, TheVax Genetics Vaccine Co., Ltd., as Director, and Kaohsiung Rapid Transit Corp., as Head-Public Affairs Department.
Mr. Chang received his Masters Business Admin degree from National Taiwan University and undergraduate degree from Taipei Medical University.